Royalty Pharma
RPRX
RPRX
583 hedge funds and large institutions have $16.9B invested in Royalty Pharma in 2026 Q1 according to their latest regulatory filings, with 114 funds opening new positions, 223 increasing their positions, 179 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 537 → 583 (+46)
7% more funds holding in top 10
Funds holding in top 10: 14 → 15 (+1)
0.59% less ownership
Funds ownership: 83.75% → 83.17% (-0.59%)
Holders
583
Holding in Top 10
15
Calls
$42.8M
Puts
$14.9M
Top Buyers
| 1 | +$352M | |
| 2 | +$171M | |
| 3 | +$159M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$98.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$75.5M |
Top Sellers
| 1 | -$513M | |
| 2 | -$187M | |
| 3 | -$114M | |
| 4 |
Jane Street
New York
|
-$112M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$57.1M |
